Skip to Content

Join the 'Etretinate' group to help and get support from people like you.

Etretinate News

FDA Approves Injectable Psoriasis Drug for Tough Cases

Posted 3 days ago by Drugs.com

THURSDAY, Feb. 16, 2017 – A new drug to treat tough cases of the skin condition psoriasis has won approval from the U.S. Food and Drug Administration. Valeant Pharmaceuticals' injectable drug Siliq (brodalumab) was approved for adults with moderate-to-severe psoriasis that isn't responding to other recommended treatments. However, the drug carries a warning about increased risk for suicidal behavior. Psoriasis is characterized by raised patches of red skin and flaking. The condition usually begins between ages 15 and 35 and is thought to be an autoimmune disorder, meaning the body mistakenly attacks healthy cells. "Moderate-to-severe plaque psoriasis can cause significant skin irritation and discomfort for patients, and today's approval provides patients with another treatment option for their psoriasis," said the FDA's Dr. Julie Beitz. Beitz is director of the Office of Drug ... Read more

Related support groups: Methotrexate, Psoriasis, Plaque Psoriasis, Soriatane, Tazorac, Dovonex, Taclonex, Oxsoralen, Acitretin, Tazarotene, Calcipotriene, Resorcinol, Enstilar, Vectical, Methoxsalen, Anthralin, Methotrexate LPF Sodium, Avage, Psoriatec, Dritho-Scalp

Worse Psoriasis, Less Healthy Arteries, Study Finds

Posted 8 Oct 2015 by Drugs.com

THURSDAY, Oct. 8, 2015 – The skin disorder psoriasis appears linked with artery inflammation, raising the odds for heart disease, a new study says. "As the amount of psoriasis increases, the amount of blood vessel inflammation increases," said senior investigator Dr. Nehal Mehta, a clinical investigator with the U.S. National Heart, Lung, and Blood Institute. His team also found that even mild psoriasis may indicate an increased risk for heart attack and stroke. Just one psoriasis skin patch, or plaque, "might be biologically active, causing low-grade inflammation and starting a cascade, speeding up their blood vessel disease," Mehta said. "People really should know that psoriasis is not just a cosmetic disease," he added. However, these study findings only show an association between psoriasis and blood vessel inflammation, not a direct cause-and-effect relationship, Mehta said. His ... Read more

Related support groups: Methotrexate, Psoriasis, Inflammatory Conditions, Plaque Psoriasis, Coronary Artery Disease (CAD), Soriatane, Tazorac, Dovonex, Acute Coronary Syndrome, Taclonex, Oxsoralen, Acitretin, Calcipotriene, Tazarotene, Acute Coronary Syndrome - Prophylaxis, Anthralin, Vectical, Resorcinol, Psoriatec, Trexall

Ask a Question

Further Information

Related Condition Support Groups

Psoriasis

Related Drug Support Groups

Tegison